18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease.
Relkin NR, Szabo P, Adamiak B, Burgut T, Monthe C, Lent RW, Younkin S, Younkin L, Schiff R, Weksler ME.
Relkin NR, et al. Among authors: weksler me.
Neurobiol Aging. 2009 Nov;30(11):1728-36. doi: 10.1016/j.neurobiolaging.2007.12.021. Epub 2008 Feb 21.
Neurobiol Aging. 2009.
PMID: 18294736
Clinical Trial.